Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injections for Myogenous Temporomandibular Disorders
NCT07606378Not yet recruiting
- Sponsor
- Karolinska Institutet
- Start
- Aug 2026
- Primary completion
- Aug 2026
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich plasma injection in Myogenous temporomandibular disorder (M-TMD) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Change in Pain Intensity at 3 months. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
platelet-rich plasma injection
03
Conditions
Myogenous temporomandibular disorder (M-TMD)
Beyond the preview
Go deeper on NCT07606378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07606378.